George A. Scangos, Ph.D

Chief Executive Officer
Biogen Idec

George A. Scangos, Ph.D. was appointed chief executive officer and a member of the board of directors in June 2010. He joins Biogen Idec from Exelixis, Inc., where he has served as president and chief executive officer and a director since October 1996. From September 1993 to October 1996, Scangos served as president of Bayer Biotechnology, where he was responsible for research, business development, process development, manufacturing, engineering and quality assurance of Bayer’s biological products. Before joining Bayer in 1987, Scangos was a professor of biology at Johns Hopkins University for six years. Scangos has served as non-executive chairman of Anadys Pharmaceuticals, Inc. since 2005 and has been a director of the company since 2003. Scangos also serves as the chair of CHI-California Healthcare Institute, a member of the board of the Global Alliance for TB Drug Development, and as a director of Fondation Santé and BayBio. He is also a member of the board of visitors of the University of California, San Francisco School of Pharmacy, and the national board of visitors of the University of California, Davis School of Medicine. He is currently an adjunct professor of biology at Johns Hopkins. Scangos was a Jane Coffin Childs Post-Doctoral Fellow at Yale University. He  holds a bachelor’s in biology from Cornell University and a doctorate degree in microbiology from the University of Massachusetts.